Findings into a new cystic fibrosis therapy aimed at extending the lives of sufferers has been unveiled by the European Respiratory Society Congress.
The new treatment involves a tablet that merges three drugs.
Developed in the United States, it's currently being trialed at Brisbane’s Prince Charles Hospital.
Share





